Press Release - A drug currently approved for smallpox in the U.S. will undergo clinical trials to treat patients infected by the Mpox viruswho are at risk of severe complications in the Democratic ...

The World Health Organization will convene a meeting of its Emergency Committee next week to determine whether mpox remains a ...

Private insurance companies in the U.S. aren’t required to cover the cost of the mpox vaccine, which costs $270 a dose.

The World Health Organisation and the Africa Centres for Disease Control and Prevention have committed to guiding the ...

This update highlights pivotal events in the health sector, including FDA approvals for heart devices, RSV vaccine success in ...

In an early sign that the mpox outbreak in Africa might be ebbing, some health officials report that case counts seem to be stabilizing in the Congo, the epicenter of the outbreak.

The Congressional Budget Office estimates that if subsidies are allowed to expire next year, nearly 4 million people will lose their coverage in 2026 because they won’t be able to afford it, NBC News ...

Your premium access has ended, but the best of Nation.Africa is still within reach. Renew now to unlock exclusive stories and ...

Georgios Pappas, a physician and zoonotic disease researcher, worries that another WHO exit would weaken the U.S.’s standing ...

Patients with mpox (previously monkeypox ... prevention measures including pre- and post-exposure prophylaxis and provision of immunization against vaccine-preventable STIs including mpox. Patients ...

Emergent BioSolutions raised its revenue guidance and dropped a going concern warning. Its CEO is billing this next chapter ...

The Africa Centre for Disease Control is urging the U.S. to maintain financial and vaccine support for its mpox outbreak response, initially pledged by President Joe Biden. Concerns have arisen over ...